• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.62% Nasdaq Up 0.35%

    Novo Nordisk A/S (NVO)

    -NYSE
    47.91 Up 1.33(2.86%) 4:02PM EST
    |After Hours : 48.93 Up 1.02 (2.12%) 5:17PM EST
    Prev Close:46.58
    Open:48.55
    Bid:47.77 x 100
    Ask:47.93 x 100
    1y Target Est:60.10
    Beta:0.348049
    Next Earnings Date:N/A
    Day's Range:47.64 - 49.20
    52wk Range:42.68 - 60.34
    Volume:4,300,742
    Avg Vol (3m):1,368,430
    Market Cap:122.32B
    P/E (ttm):23.62
    EPS (ttm):2.03
    Div & Yield:0.73 (1.49%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVOUp 2.86%122.32B
    PFEUp 1.34%182.06B
    LLYDown 0.22%77.38B

    Key Statistics

    Forward P/E (1 yr):19.56
    P/S (ttm):7.35
    Ex-Dividend Date:19-Mar-15

    Analysts

    Annual EPS Est (Dec-16) :2.26
    Quarterly EPS Est (Mar-16) :N/A
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):1.91

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback